We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GURE:NASDAQGulf Resources, Inc. Analysis

Data as of 2026-05-19 - not real-time

$3.85

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Gulf Resources, Inc. (GURE) is trading at $3.85, well below its 20‑day SMA of 3.94 and the 50‑day SMA of 4.81, indicating a bearish price stance. The 14‑day RSI sits at 44, suggesting neutral momentum but no near‑term oversold condition. MACD shows a bullish crossover (‑0.34 line above ‑0.42 signal) with a small positive histogram, offering a faint technical upside. Volume is on a decreasing trend and the market cap is under $6 M, highlighting liquidity constraints. Volatility over the past 30 days is extreme at 149 %, and beta is low at 0.30, meaning price swings are large but not strongly correlated with the market. The DCF‑derived fair value of $87.92 versus the current price implies a massive valuation gap. The Fear & Greed Index reads Extreme Greed (88.98), reflecting market euphoria that may be overlooking the company’s fundamentals.
Fundamentally, GURE reports negative gross (‑28 %) and operating margins (‑4 %), a trailing EPS of ‑$49.34, and a max drawdown of ‑72 %, underscoring severe profitability issues. Debt‑to‑equity is high at 7.5 and free cash flow is deeply negative, raising solvency concerns. A recent NASDAQ notice for late filing of the annual report adds regulatory risk. With a price‑to‑book of only 0.05 and a PB ratio that is dramatically low, the stock appears deeply discounted but fraught with risk. The overall picture is one of a severely distressed company that is technically bearish, highly volatile, and facing liquidity and compliance challenges despite an apparent valuation upside.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price below short‑term moving averages
  • decreasing volume and high volatility
  • regulatory filing delinquency

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • massive DCF upside potential
  • ongoing profitability and cash‑flow deficits
  • uncertain debt restructuring outlook

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • extreme price discount to fair value
  • potential industry demand for bromine and salt
  • possibility of turnaround after financial restructuring

Key Metrics & Analysis

Financial Health

Revenue Growth303.40%
Profit Margin-286.76%
ROE-43.38%
ROA-4.60%
Debt/Equity7.50
P/B Ratio0.0
Op. Cash Flow$5.5M
Free Cash Flow$-12061764

Technical Analysis

TrendBearish
RSI44.0
Support$3.20
Resistance$5.69
MA 20$3.94
MA 50$4.81
MA 200$5.16
MACDBullish
VolumeDecreasing
Fear & Greed Index88.98

Valuation

Fair Value$87.92
GradeUndervalued
TypeValue

Risk Assessment

Beta0.30
Volatility149.39%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.